Prescribing

Prescribing FAQs


Blogs relating to prescribing

Nice | Empagliflozin in Type 2 Diabetes

This is a new guideline from Nice. Empagliflozin is a selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor, which blocks glucose reabsorption in the kidneys and so causes increased urinary excr...

Read more

FSRH | Depot contraception

This is an updated guideline on the injectable contraceptive from the FSRH. The main new advice is that although women should be advised to swap to an alternative form of contraception after age 50, t...

Read more

Nice | Vitamin D supplementation

This public health guideline from NICE summarises the actions needed to increase the use of Vitamin D supplementation. This guidance was released by the Chief Medical Officer a couple of years ago. Th...

Read more

Raising concerns about poor prescribing

MPS Medicolegal Consultant Dr Rachel Birch shares a case scenario involving a locum GP who was working in a practice with poor prescribing issues Dr L was working three days a week as a maternity locu...

Read more

Nice | Canagliflozin in Type 2 diabetes

This new guideline from NICE outlines when canagliflozin can be used. This is an SGLT2 inhibitor (selective sodium-glucose cotransporter-2). It blocks reabsorption of glucose in the kidneys, so increa...

Read more

FSRH | St John’s Wort and contraceptives

The FSRH have released new advice about St John's Wort use with contraceptives. It's use has been linked to pregnancies with the COC, POP and with the implant. Women should be advised when being start...

Read more

NSAIDs

Aimee Lettis from the GP Update team gives us short, sharp nuggets of clinical information for sessional GPs. They’re one of the commonest painkillers used in primary care. But if, like me, you’re alw...

Read more

Nice | Neuropathic pain

This guideline updates the advice on managing neuropathic pain. It's worth a look through as there are some changes. The main things are: Diabetic neuropathy - now to be treated in the same way as oth...

Read more

Nice | MI secondary prevention

This guideline from Nice, updates the advice regarding the secondary prevention of MI. Much of the guidance is the same. The biggest change is regarding the use of antithrombotics. I have summarised s...

Read more

Nice | Dapagliflozin for Type 2 Diabetes

This guideline advises that Dapagliflozin can be used in Type 2 Diabetes as add-on therapy: • With metformin if: - glycaemic control is not adequate - a sulphonylurea can not be used - its addition gi...

Read more